Showing results (91-100 of 103) with videos related to
Sort By:
Pageof 11
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Preclinical evaluation of chimeric L6 antibody for the treatment of Kaposi's sarcoma with radioimmunotherapyB R Leigh, P A Burke, A M Hong, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
67Copper-2-iminothiolane-6-[p-(bromoacetamido)benzyl-TETA-Lym-1 for radioimmunotherapy of non-Hodgkin's lymphomaR T O'Donnell, G L DeNardo, D L Kukis, et al.Proceedings of the National Academy of Sciences of the United States of America|April 15, 1997
Synergy of Taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: efficacy and toxicity in breast cancer xenograftsS J DeNardo, D L Kukis, L A Kroger, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 5, 2000
A clinical trial of radioimmunotherapy with 67Cu-2IT-BAT-Lym-1 for non-Hodgkin's lymphomaR T O'Donnell, G L DeNardo, D L Kukis, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1997
Radioimmunotherapy for breast cancer using indium-111/yttrium-90 BrE-3: results of a phase I clinical trialS J DeNardo, E L Kramer, R T O'Donnell, et al.Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Radioimmunotherapy of acquired immunodeficiency syndrome (AIDS) associated lymphomaR T O'Donnell, B R Leigh, S D Christensen, et al.Cancer|December 24, 1997
Enhancement of 67Cu-2IT-BAT-LYM-1 therapy in mice with human Burkitt's lymphoma (Raji) using interleukin-2G L DeNardo, D L Kukis, S J DeNardo, et al.American Journal of Veterinary Research|July 1, 1987
Rhinitis, pneumonia, and defective neutrophil function in the Doberman pinscherE B Breitschwerdt, T T Brown, E V De Buysscher, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Dosimetry-based therapy in metastatic breast cancer patients using 90Y monoclonal antibody 170H.82 with autologous stem cell support and cyclosporin AC M Richman, S J DeNardo, R T O'Donnell, et al.Cancer Biotherapy & Radiopharmaceuticals|March 31, 2000
Neovascular targeting with cyclic RGD peptide (cRGDf-ACHA) to enhance delivery of radioimmunotherapyS J DeNardo, P A Burke, B R Leigh, et al.Pageof 11